CBER Hits Performance Goals

The Center for Biologics Research and Evaluation said it met its performance goals for reviewing and acting on applications and supplements for biologics.

In a report, CBER Director Peter Marks said 100 percent of standard and priority BLAs were reviewed on time.

Last year, CBER published 12 guidance documents — four of which were released in cooperation with CDER or CDRH.